Vycellix
Business Services · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4105 E Fowler Ave, Tampa, Florida, 33617...Phone Number
(772) 418-6302Website
www.vycellix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Vycellix
Vycellix is focused on developing innovative allogeneic medicines aimed at eliminating the risk of immune rejection in patients. The company offers a range of products and services, including Universal Cells, Tumor-Activated Engagers, and BioTools. Their pipeline features advanced therapies like VNK-101 and Multi-Antigen Engager. Vycellix primarily targets patients in need of cutting-edge cell therapies, with operations in the USA and Sweden.Explore more
Vycellix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vycellix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Vycellix
Check if Vycellix has recently received funding, and reach out quickly before it becomes old news!
Check out if Vycellix is spiking on competitors!
Vycellix, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Vycellix had a recent Job posting/layoffs
Product Launch: Get notified when Vycellix launches new products
Funding: Get notified immidiatlly once Vycellix has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Vycellix recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Vycellix as Masked Content
Find 2 more new buyers
Compare Similar Companies to Vycellix
Compare insights from companies similar to Vycellix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vycellix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Vycellix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Vycellix.
Vycellix Tech Stack
A closer look at the technologies used by Vycellix
Vycellix News & Media
Coeptis Therapeutics Partners with VyGen-Bio, Inc. to Co-develop Two Assets Designed to Improve the Treatment of CD38-Related Cancers
WEXFORD, Pa., Aug. 19, 2021 /PRNewswire/ -- Coeptis Therapeutics, Inc. (OTC PINK: COEP), a pharmaceutical company focused on the development of innovative technologies designed to disrupt conventional treatment paradigms and improve patient outcomes, today announced it has exercised its...Coeptis Pharmaceuticals Enters into Exclusive Option Agreements with VyGen-Bio to Co-develop Technologies Designed to Improve the Treatment of CD38-Related Cancers
WEXFORD, Pa., May 18, 2021 /PRNewswire/ -- Coeptis Pharmaceuticals, Inc., a wholly-owned subsidiary of Vinings Holdings Inc. (OTC PINK: NDYN), today announced entry into two separate exclusive option agreements with VyGen-Bio, Inc., a majority-owned subsidiary of Vycellix, Inc., involving...Vycellix to Present at Upcoming Life Science Conferences
TAMPA, Fla. & STOCKHOLM--(BUSINESS WIRE)-- #nkcell--Vycellix to present its NK cell cancer immunotherapy platforms at upcoming life science conferences.Vycellix CEO to Present its Universal Cell Program (VY-UC) for Off-the-Shelf NK Cell Therapy at Allogeneic Cell Therapies Summit
TAMPA, Fla. & STOCKHOLM--(BUSINESS WIRE)-- #celltherapy--Vycellix, Inc., an immuno-centric discovery life science company with a focus on natural killer cell-based (NK cell) therapeutics, today announced that its Chairman & CEO, Evren Alici, M.D., Ph.D., will present at the upcoming Allogeneic Cell Therapies Summit. The Conference, which will be held as a virtual event on October 26-28, is focused on the clinical and commercial development of engineered allogeneic cell therapies with improved ma
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vycellix
Sign Up For FreeTo access detailed company insights
Vycellix is focused on developing innovative allogeneic medicines aimed at eliminating the risk of immune rejection in patients. The company offers a range of products and services, including Universal Cells, Tumor-Activated Engagers, and BioTools. Their pipeline features advanced therapies like VNK-101 and Multi-Antigen Engager. Vycellix primarily... Read More
